Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 17/20 | 0.46 |
| ▸ | PDCD1 | Q15116 | 4/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16239319 | 0.81 | CD274 (0.51) | CD274PDCD1FFAR1S1PR1 | |
| SCHEMBL15125788 | 0.81 | CD274 (0.51) | CD274PDCD1FFAR1S1PR1 | |
| SCHEMBL9933567 | 0.79 | CD274 (0.42) | CD274PDCD1FFAR1S1PR1S1PR3 | |
| SCHEMBL15494593 | 0.79 | CD274 (0.42) | CD274PDCD1FFAR1S1PR1S1PR3 | |
| SCHEMBL562649 | 0.77 | CHEK1 (0.44) | CD274PDCD1FYN | |
| SCHEMBL12641067 | 0.77 | CD274 (0.56) | CD274PDCD1FFAR1S1PR1S1PR3 | |
| SCHEMBL10010968 | 0.77 | FFAR1 (0.48) | CD274PDCD1FFAR1 | |
| SCHEMBL562696 | 0.77 | PDCD1 (0.63) | CD274PDCD1FFAR1S1PR1S1PR3 | |
| SCHEMBL13092124 | 0.75 | CD274 (0.39) | CD274PDCD1FFAR1S1PR1S1PR3 | |
| SCHEMBL10264618 | 0.75 | ALDH1A1 (0.46) | CD274PDCD1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2423176-A1 | CARBOXYLIC ACID COMPOUND | Astellas Pharma Inc. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120035196-A1 | CARBOXYLIC ACID COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035196-A1 | CARBOXYLIC ACID COMPOUND | ASTELLAS PHARMA INC. (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035196-A1 | CARBOXYLIC ACID COMPOUND | GPR119, GPR65, GPR55 | CD274 3683/4885PDCD1 4394/4885FFAR1 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.